|
1
|
Goodman MC, Chang P, Minteer W, Nguyen D, Gopalkrishnan K, Phan J. Patient Complications and Device Issues Associated With FDA-Approved Intragastric Balloons Available in the USA: A Maude Database Study. Obes Surg 2024; 34:1971-1974. [PMID: 38467899 PMCID: PMC11031455 DOI: 10.1007/s11695-024-07128-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2023] [Revised: 02/19/2024] [Accepted: 02/22/2024] [Indexed: 03/13/2024]
Affiliation(s)
- Morgan C Goodman
- Division of Gastrointestinal and Liver Diseases, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
| | - Patrick Chang
- Division of Gastrointestinal and Liver Diseases, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| | - William Minteer
- Division of Gastrointestinal and Liver Diseases, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| | - Denis Nguyen
- Department of Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| | - Kalpana Gopalkrishnan
- Department of Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| | - Jennifer Phan
- Division of Gastrointestinal and Liver Diseases, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| |
Collapse
|
|
2
|
Abstract
Nonadherence to medical treatment is exceptionally common and associated with poor clinical outcomes, a negative impact on quality of life, and a large financial burden on health care systems. This article first addresses key contributors to nonadherence from patient-specific, treatment-specific, and health care system-specific factors. Second, it outlines tools for the practicing clinician to identify, evaluate, and manage nonadherence across the spectrum of chronic disease in partnership with patients.
Collapse
Affiliation(s)
| | - William Minteer
- Division of Community Internal Medicine, Mayo Clinic, Rochester, MN, USA
| | - Kasey R Boehmer
- Division of Health Care Delivery Research, Knowledge and Evaluation Research (KER) Unit, Mayo Clinic, Rochester, MN, USA.
| |
Collapse
|
|
3
|
Bernstein M, Hari A, Aggarwal S, Lee D, Farfel A, Patel P, Raman K, Raja S, Fenning R, Lieber M, Minteer W, Denny S, Ries M. Implementation of a human papillomavirus screen-and-treat model in Mwanza, Tanzania: training local healthcare workers for sustainable impact. Int Health 2019; 10:197-201. [PMID: 29579207 DOI: 10.1093/inthealth/ihy014] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2017] [Accepted: 02/14/2018] [Indexed: 11/14/2022] Open
Abstract
Background The purpose of this study is to evaluate the development of a 1-wk screening campaign and efforts towards the implementation of a sustainable system that addresses cervical cancer in Mwanza, Tanzania with a screen-and-treat model utilizing visual inspection of the cervix with acetic acid (VIA) and cryotherapy. Methods In partnership with CureCervicalCancer (CCC), a non-profit organization based in Los Angeles, CA, USA, 11 medical students at the University of California, Irvine School of Medicine established a model for sustainable human papillomavirus screening practices in Mwanza, Tanzania. This study both quantitatively and qualitatively assesses the successes and limitations of the program model. Results During the 5-day training, a total of 614 women attended the screenings and 556 women were screened with VIA, of whom 10.6% (n=59) were VIA positive and 89.4% (n=499) were VIA negative. Of those who were VIA positive, 83.1% (n=49) received cryotherapy while 16.9% (n=10) did not due to suspicion of advanced cancer (n=7), refusal to receive cryotherapy (n=2) or pregnancy (n=1). Conclusions The screen-and-treat model for the identification and treatment of precancerous cervical lesions is an effective public health intervention with the potential to impact women by providing the tools and education needed by local healthcare professionals. However, limitations common to resource-poor settings, such as continuity of funding, loss to follow-up and transportation costs, remain barriers to sustainability.
Collapse
Affiliation(s)
- Megan Bernstein
- University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Anjali Hari
- University of California, Los Angeles, Department of Obstetrics and Gynecology, Los Angeles, CA, USA
| | - Sahil Aggarwal
- University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Debora Lee
- University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Allison Farfel
- University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Priya Patel
- University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Kaavya Raman
- University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Shella Raja
- University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Reece Fenning
- University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Mark Lieber
- University of California, Irvine School of Medicine, Irvine, CA, USA
| | - William Minteer
- University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Sean Denny
- University of California, Irvine School of Medicine, Irvine, CA, USA
| | - Maureen Ries
- University of California, Los Angeles, Department of Obstetrics and Gynecology, Los Angeles, CA, USA
| |
Collapse
|